AUPH R&D Expense Growth
Aurinia Pharmaceuticals Inc · R&D Expense Growth
AUPH R&D Expense Growth
Latest reported56.39%period ending
AUPH FY R&D Growth (YoY) (0.00% → 56.39%)
Latest values, visible window
High-resolution chart · PNG
AUPH r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 56.3868% | |
| -58.1294% | |
| 10.3428% | |
| -12.028% | |
| 1.6134% | |
| -4.8027% | |
| 27.7512% | |
| 21.9629% | |
| 133.4526% | |
| -9.0602% | |
| 75.3951% | |
| 371.2088% | |
| -64.9014% | |
| 58.5006% | |
| -12.8682% | |
| -47.8625% | |
| -33.1322% | |
| -61.4679% | |
| 56.2679% | |
| -2.2707% | |
| 43.827% | |
| 48.1904% | |
| 28.3912% | |
| -15.5022% | |
| 75.9963% | |
| 235.0599% | |
| -0.4318% | |
| 0% |